
Droncit® (praziquantel) is an FDA-approved preparation containing praziquantel, for veterinary use. Available by prescription.
Veterinarians most commonly consider Droncit® for patients presented with tapeworm infections. At a pharmacological level, it manages the permeability of the parasite's cell membrane to calcium ions. This mechanism induces contraction and paralysis of the parasite, providing a method for the pet's immune system to address the infection. Your veterinarian will determine appropriateness based on fecal diagnostic results or clinical observations.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects include localized digestive changes such as increased salivation, vomiting or diarrhea. Some pets may exhibit temporary behavioral shifts such as lethargy or a decrease in energy. Owners should monitor their pet for any unusual signs of discomfort and contact their veterinarian promptly with any concerns. It is typically evaluated carefully in pregnant animals. Because tapeworms are often associated with fleas, your veterinarian may also discuss concurrent flea management protocols.
Yes. Droncit® is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies authorization before preparing any medication.
Yes. Mixlab specializes in compounding praziquantel into flavored oral liquids or treats when the commercial format is not suitable for your pet. The decision rests with your prescribing veterinarian.
Tapeworms are frequently associated with the ingestion of fleas or small rodents. Your veterinarian will often discuss a comprehensive management approach that includes both deworming and flea prevention.
Because Droncit® manages the integrity of the parasite, tapeworms are often digested within the intestinal tract. You may not always see observational evidence of the worms in your pet's stool after administration.
Your veterinarian will provide guidance on the necessary frequency of use based on your pet's lifestyle and risk of re-infection. They will determine the most suitable monitoring schedule.




